HEADER OXIDOREDUCTASE 25-MAY-21 7EWH TITLE CRYSTAL STRUCTURE OF HUMAN PHGDH IN COMPLEX WITH HOMOHARRINGTONINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: D-3-PHOSPHOGLYCERATE DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3-PGDH,2-OXOGLUTARATE REDUCTASE,MALATE DEHYDROGENASE; COMPND 5 EC: 1.1.1.95,1.1.1.399,1.1.1.37; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PHGDH, PGDH3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS INHIBITOR, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR C.H.HSIEH,Y.S.CHENG,Y.S.LEE,H.C.HUANG,H.F.JUAN REVDAT 3 20-DEC-23 7EWH 1 JRNL REVDAT 2 29-NOV-23 7EWH 1 REMARK REVDAT 1 07-DEC-22 7EWH 0 JRNL AUTH C.H.HSIEH,C.T.HUANG,Y.S.CHENG,C.H.HSU,W.M.HSU,Y.H.CHUNG, JRNL AUTH 2 Y.L.LIU,T.S.YANG,C.Y.CHIEN,Y.H.LEE,H.C.HUANG,H.F.JUAN JRNL TITL HOMOHARRINGTONINE AS A PHGDH INHIBITOR: UNRAVELING METABOLIC JRNL TITL 2 DEPENDENCIES AND DEVELOPING A POTENT THERAPEUTIC STRATEGY JRNL TITL 3 FOR HIGH-RISK NEUROBLASTOMA. JRNL REF BIOMED PHARMACOTHER V. 166 15429 2023 JRNL REFN ESSN 1950-6007 JRNL PMID 37673018 JRNL DOI 10.1016/J.BIOPHA.2023.115429 REMARK 2 REMARK 2 RESOLUTION. 2.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.56 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 76.0 REMARK 3 NUMBER OF REFLECTIONS : 9221 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.348 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.180 REMARK 3 FREE R VALUE TEST SET COUNT : 939 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.5550 - 5.7044 0.97 1536 171 0.2271 0.3117 REMARK 3 2 5.7044 - 4.5343 0.93 1459 162 0.2517 0.3195 REMARK 3 3 4.5343 - 3.9630 0.89 1372 157 0.2146 0.3316 REMARK 3 4 3.9630 - 3.6015 0.83 1283 147 0.2187 0.3873 REMARK 3 5 3.6015 - 3.3439 0.70 1087 124 0.2548 0.3826 REMARK 3 6 3.3439 - 3.1470 0.60 932 108 0.2847 0.4520 REMARK 3 7 3.1470 - 2.9900 0.40 613 70 0.2870 0.4160 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.580 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 39.700 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A REMARK 3 SELECTION : CHAIN B REMARK 3 ATOM PAIRS NUMBER : 1828 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7EWH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1300022172. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JAN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9221 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.990 REMARK 200 RESOLUTION RANGE LOW (A) : 27.555 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 76.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.13600 REMARK 200 R SYM (I) : 0.15900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0020 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2G76 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 MM MMT BUFFER, PH 7.0 WITH 30% REMARK 280 PEG4000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 60.31950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU B 283 OG SER B 286 2.00 REMARK 500 O LEU A 283 NH2 ARG B 118 2.11 REMARK 500 NZ LYS A 128 O VAL B 272 2.17 REMARK 500 O LEU A 209 N THR A 213 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 89 CB ARG A 89 CG -0.197 REMARK 500 VAL B 29 CB VAL B 29 CG2 -0.249 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 89 CG - CD - NE ANGL. DEV. = -15.9 DEGREES REMARK 500 ARG A 89 NH1 - CZ - NH2 ANGL. DEV. = 9.1 DEGREES REMARK 500 ARG A 89 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG A 89 NE - CZ - NH2 ANGL. DEV. = -12.8 DEGREES REMARK 500 CYS A 115 CA - CB - SG ANGL. DEV. = 7.2 DEGREES REMARK 500 ARG A 293 NE - CZ - NH1 ANGL. DEV. = -3.1 DEGREES REMARK 500 LEU B 9 CA - CB - CG ANGL. DEV. = -25.2 DEGREES REMARK 500 LYS B 32 CD - CE - NZ ANGL. DEV. = -24.8 DEGREES REMARK 500 LEU B 84 CB - CG - CD1 ANGL. DEV. = -20.8 DEGREES REMARK 500 LEU B 84 CB - CG - CD2 ANGL. DEV. = 15.5 DEGREES REMARK 500 LEU B 93 CB - CG - CD2 ANGL. DEV. = 16.0 DEGREES REMARK 500 ARG B 118 N - CA - C ANGL. DEV. = 19.4 DEGREES REMARK 500 LEU B 190 CA - CB - CG ANGL. DEV. = 18.8 DEGREES REMARK 500 SER B 250 CB - CA - C ANGL. DEV. = 17.5 DEGREES REMARK 500 ASP B 304 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 6 27.76 -154.91 REMARK 500 SER A 11 22.09 -73.81 REMARK 500 ASP A 24 42.84 -90.13 REMARK 500 GLU A 31 39.70 -96.64 REMARK 500 GLN A 33 -57.05 -164.65 REMARK 500 ASN A 34 10.02 -35.67 REMARK 500 SER A 36 -168.28 -65.03 REMARK 500 GLU A 39 -16.91 -149.87 REMARK 500 ARG A 53 -49.65 -134.21 REMARK 500 SER A 54 -61.56 -148.14 REMARK 500 THR A 56 73.67 43.35 REMARK 500 THR A 59 -174.98 -66.54 REMARK 500 GLN A 70 -17.09 -142.28 REMARK 500 ASP A 80 31.14 -98.30 REMARK 500 ASN A 81 -1.26 -155.67 REMARK 500 ASN A 96 -166.56 -126.22 REMARK 500 GLU A 133 71.87 -101.29 REMARK 500 PHE A 137 51.91 -104.95 REMARK 500 LEU A 152 -167.05 -116.59 REMARK 500 ARG A 154 -73.03 -57.01 REMARK 500 SER A 184 0.54 -52.54 REMARK 500 PHE A 185 34.46 -143.94 REMARK 500 THR A 206 136.87 -33.36 REMARK 500 LYS A 225 -74.70 -2.00 REMARK 500 LYS A 226 152.68 137.78 REMARK 500 ALA A 234 -112.19 -112.14 REMARK 500 GLU A 263 -74.99 -76.71 REMARK 500 GLU A 264 -114.91 154.56 REMARK 500 SER A 286 64.57 -107.24 REMARK 500 VAL B 8 -146.92 -119.01 REMARK 500 ASP B 24 24.20 -69.49 REMARK 500 GLU B 31 40.84 -89.08 REMARK 500 GLN B 33 96.81 148.97 REMARK 500 LEU B 35 -145.67 -110.60 REMARK 500 SER B 36 -71.55 -179.56 REMARK 500 GLU B 39 -16.19 -173.71 REMARK 500 LEU B 44 -163.05 -66.20 REMARK 500 GLN B 45 -25.35 66.06 REMARK 500 ASP B 46 -142.42 -128.84 REMARK 500 CYS B 47 161.83 70.62 REMARK 500 SER B 54 -19.68 141.76 REMARK 500 LYS B 57 84.12 -61.36 REMARK 500 THR B 59 -172.68 -59.31 REMARK 500 ALA B 66 72.45 -102.46 REMARK 500 GLN B 70 -30.84 -150.05 REMARK 500 THR B 77 135.68 -13.87 REMARK 500 ASP B 80 33.71 -94.50 REMARK 500 ASN B 81 -0.75 -156.62 REMARK 500 LYS B 90 -94.50 -96.88 REMARK 500 GLN B 119 46.34 97.03 REMARK 500 REMARK 500 THIS ENTRY HAS 58 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 34 LEU A 35 -134.18 REMARK 500 LYS B 7 VAL B 8 -144.74 REMARK 500 ASN B 34 LEU B 35 -147.12 REMARK 500 LEU B 69 GLN B 70 136.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HMT A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HMT B 400 DBREF 7EWH A 5 306 UNP O43175 SERA_HUMAN 6 307 DBREF 7EWH B 5 306 UNP O43175 SERA_HUMAN 6 307 SEQRES 1 A 302 LEU ARG LYS VAL LEU ILE SER ASP SER LEU ASP PRO CYS SEQRES 2 A 302 CYS ARG LYS ILE LEU GLN ASP GLY GLY LEU GLN VAL VAL SEQRES 3 A 302 GLU LYS GLN ASN LEU SER LYS GLU GLU LEU ILE ALA GLU SEQRES 4 A 302 LEU GLN ASP CYS GLU GLY LEU ILE VAL ARG SER ALA THR SEQRES 5 A 302 LYS VAL THR ALA ASP VAL ILE ASN ALA ALA GLU LYS LEU SEQRES 6 A 302 GLN VAL VAL GLY ARG ALA GLY THR GLY VAL ASP ASN VAL SEQRES 7 A 302 ASP LEU GLU ALA ALA THR ARG LYS GLY ILE LEU VAL MET SEQRES 8 A 302 ASN THR PRO ASN GLY ASN SER LEU SER ALA ALA GLU LEU SEQRES 9 A 302 THR CYS GLY MET ILE MET CYS LEU ALA ARG GLN ILE PRO SEQRES 10 A 302 GLN ALA THR ALA SER MET LYS ASP GLY LYS TRP GLU ARG SEQRES 11 A 302 LYS LYS PHE MET GLY THR GLU LEU ASN GLY LYS THR LEU SEQRES 12 A 302 GLY ILE LEU GLY LEU GLY ARG ILE GLY ARG GLU VAL ALA SEQRES 13 A 302 THR ARG MET GLN SER PHE GLY MET LYS THR ILE GLY TYR SEQRES 14 A 302 ASP PRO ILE ILE SER PRO GLU VAL SER ALA SER PHE GLY SEQRES 15 A 302 VAL GLN GLN LEU PRO LEU GLU GLU ILE TRP PRO LEU CYS SEQRES 16 A 302 ASP PHE ILE THR VAL HIS THR PRO LEU LEU PRO SER THR SEQRES 17 A 302 THR GLY LEU LEU ASN ASP ASN THR PHE ALA GLN CYS LYS SEQRES 18 A 302 LYS GLY VAL ARG VAL VAL ASN CYS ALA ARG GLY GLY ILE SEQRES 19 A 302 VAL ASP GLU GLY ALA LEU LEU ARG ALA LEU GLN SER GLY SEQRES 20 A 302 GLN CYS ALA GLY ALA ALA LEU ASP VAL PHE THR GLU GLU SEQRES 21 A 302 PRO PRO ARG ASP ARG ALA LEU VAL ASP HIS GLU ASN VAL SEQRES 22 A 302 ILE SER CYS PRO HIS LEU GLY ALA SER THR LYS GLU ALA SEQRES 23 A 302 GLN SER ARG CYS GLY GLU GLU ILE ALA VAL GLN PHE VAL SEQRES 24 A 302 ASP MET VAL SEQRES 1 B 302 LEU ARG LYS VAL LEU ILE SER ASP SER LEU ASP PRO CYS SEQRES 2 B 302 CYS ARG LYS ILE LEU GLN ASP GLY GLY LEU GLN VAL VAL SEQRES 3 B 302 GLU LYS GLN ASN LEU SER LYS GLU GLU LEU ILE ALA GLU SEQRES 4 B 302 LEU GLN ASP CYS GLU GLY LEU ILE VAL ARG SER ALA THR SEQRES 5 B 302 LYS VAL THR ALA ASP VAL ILE ASN ALA ALA GLU LYS LEU SEQRES 6 B 302 GLN VAL VAL GLY ARG ALA GLY THR GLY VAL ASP ASN VAL SEQRES 7 B 302 ASP LEU GLU ALA ALA THR ARG LYS GLY ILE LEU VAL MET SEQRES 8 B 302 ASN THR PRO ASN GLY ASN SER LEU SER ALA ALA GLU LEU SEQRES 9 B 302 THR CYS GLY MET ILE MET CYS LEU ALA ARG GLN ILE PRO SEQRES 10 B 302 GLN ALA THR ALA SER MET LYS ASP GLY LYS TRP GLU ARG SEQRES 11 B 302 LYS LYS PHE MET GLY THR GLU LEU ASN GLY LYS THR LEU SEQRES 12 B 302 GLY ILE LEU GLY LEU GLY ARG ILE GLY ARG GLU VAL ALA SEQRES 13 B 302 THR ARG MET GLN SER PHE GLY MET LYS THR ILE GLY TYR SEQRES 14 B 302 ASP PRO ILE ILE SER PRO GLU VAL SER ALA SER PHE GLY SEQRES 15 B 302 VAL GLN GLN LEU PRO LEU GLU GLU ILE TRP PRO LEU CYS SEQRES 16 B 302 ASP PHE ILE THR VAL HIS THR PRO LEU LEU PRO SER THR SEQRES 17 B 302 THR GLY LEU LEU ASN ASP ASN THR PHE ALA GLN CYS LYS SEQRES 18 B 302 LYS GLY VAL ARG VAL VAL ASN CYS ALA ARG GLY GLY ILE SEQRES 19 B 302 VAL ASP GLU GLY ALA LEU LEU ARG ALA LEU GLN SER GLY SEQRES 20 B 302 GLN CYS ALA GLY ALA ALA LEU ASP VAL PHE THR GLU GLU SEQRES 21 B 302 PRO PRO ARG ASP ARG ALA LEU VAL ASP HIS GLU ASN VAL SEQRES 22 B 302 ILE SER CYS PRO HIS LEU GLY ALA SER THR LYS GLU ALA SEQRES 23 B 302 GLN SER ARG CYS GLY GLU GLU ILE ALA VAL GLN PHE VAL SEQRES 24 B 302 ASP MET VAL HET HMT A 400 39 HET HMT B 400 39 HETNAM HMT (3BETA)-O~3~-[(2R)-2,6-DIHYDROXY-2-(2-METHOXY-2- HETNAM 2 HMT OXOETHYL)-6-METHYLHEPTANOYL]CEPHALOTAXINE HETSYN HMT HOMOHARRINGTONINE; CEPHALOTAXINE; [3(R)]-4-METHYL 2- HETSYN 2 HMT HYDROXY-2-(4-HYDROXY-4-METHYLPENTYL)BUTANEDIOATE FORMUL 3 HMT 2(C29 H39 N O9) FORMUL 5 HOH *24(H2 O) HELIX 1 AA1 PRO A 16 ASP A 24 1 9 HELIX 2 AA2 GLU A 39 LEU A 44 1 6 HELIX 3 AA3 LEU A 84 ARG A 89 1 6 HELIX 4 AA4 ASN A 101 GLN A 119 1 19 HELIX 5 AA5 GLN A 119 LYS A 128 1 10 HELIX 6 AA6 GLY A 153 SER A 165 1 13 HELIX 7 AA7 SER A 178 SER A 184 1 7 HELIX 8 AA8 PRO A 191 TRP A 196 1 6 HELIX 9 AA9 ASN A 219 GLN A 223 5 5 HELIX 10 AB1 ASP A 240 SER A 250 1 11 HELIX 11 AB2 THR A 287 PHE A 302 1 16 HELIX 12 AB3 PRO B 16 ASP B 24 1 9 HELIX 13 AB4 ASN B 101 GLN B 119 1 19 HELIX 14 AB5 GLN B 119 LYS B 128 1 10 HELIX 15 AB6 GLY B 153 GLN B 164 1 12 HELIX 16 AB7 SER B 165 GLY B 167 5 3 HELIX 17 AB8 SER B 178 SER B 184 1 7 HELIX 18 AB9 PRO B 191 TRP B 196 1 6 HELIX 19 AC1 ASN B 217 CYS B 224 1 8 HELIX 20 AC2 ASP B 240 SER B 250 1 11 HELIX 21 AC3 HIS B 282 SER B 286 5 5 HELIX 22 AC4 THR B 287 PHE B 302 1 16 SHEET 1 AA1 2 LYS A 7 LEU A 9 0 SHEET 2 AA1 2 GLN A 28 VAL A 30 1 O GLN A 28 N VAL A 8 SHEET 1 AA2 2 VAL A 71 ARG A 74 0 SHEET 2 AA2 2 LEU A 93 ASN A 96 1 O MET A 95 N VAL A 72 SHEET 1 AA3 7 GLN A 188 GLN A 189 0 SHEET 2 AA3 7 LYS A 169 TYR A 173 1 N GLY A 172 O GLN A 188 SHEET 3 AA3 7 THR A 146 LEU A 150 1 N LEU A 147 O ILE A 171 SHEET 4 AA3 7 PHE A 201 VAL A 204 1 O THR A 203 N GLY A 148 SHEET 5 AA3 7 ARG A 229 ASN A 232 1 O VAL A 231 N ILE A 202 SHEET 6 AA3 7 GLY A 255 LEU A 258 1 O ALA A 257 N ASN A 232 SHEET 7 AA3 7 VAL A 277 ILE A 278 1 O ILE A 278 N LEU A 258 SHEET 1 AA4 2 VAL B 8 LEU B 9 0 SHEET 2 AA4 2 VAL B 29 VAL B 30 1 O VAL B 30 N VAL B 8 SHEET 1 AA5 2 VAL B 72 GLY B 73 0 SHEET 2 AA5 2 VAL B 94 MET B 95 1 O MET B 95 N VAL B 72 SHEET 1 AA6 7 VAL B 187 GLN B 189 0 SHEET 2 AA6 7 LYS B 169 TYR B 173 1 N THR B 170 O GLN B 188 SHEET 3 AA6 7 THR B 146 LEU B 150 1 N ILE B 149 O ILE B 171 SHEET 4 AA6 7 PHE B 201 VAL B 204 1 O THR B 203 N GLY B 148 SHEET 5 AA6 7 VAL B 228 ASN B 232 1 O VAL B 231 N ILE B 202 SHEET 6 AA6 7 CYS B 253 LEU B 258 1 O ALA B 257 N ASN B 232 SHEET 7 AA6 7 VAL B 277 SER B 279 1 O ILE B 278 N LEU B 258 SITE 1 AC1 15 LEU A 150 GLY A 151 LEU A 152 GLY A 153 SITE 2 AC1 15 ARG A 154 ILE A 155 GLY A 156 ASP A 174 SITE 3 AC1 15 PRO A 175 ILE A 176 HIS A 205 THR A 206 SITE 4 AC1 15 PRO A 207 THR A 212 HOH A 506 SITE 1 AC2 11 LEU B 150 GLY B 151 LEU B 152 GLY B 153 SITE 2 AC2 11 ARG B 154 ILE B 155 GLY B 156 ASP B 174 SITE 3 AC2 11 PRO B 175 HIS B 205 THR B 206 CRYST1 43.165 120.639 59.480 90.00 100.72 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023167 0.000000 0.004385 0.00000 SCALE2 0.000000 0.008289 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017111 0.00000